Karel Souček
- Cancer Research top 5%
- NF-κB Signaling Pathways 7
- Oncology top 5%
- Cancer Cells and Metastasis 22
- Cancer-related Molecular Pathways 18
- Molecular Biology top 5%
- Cell death mechanisms and regulation 11
- Retinoids in leukemia and cellular processes 10
- Epigenetics and DNA Methylation 7
- Cell Biology top 5%
- Immunology top 10%
-
- Prostate Cancer Treatment and Research 9
-
- Estrogen and related hormone effects 7
- Co-authors
- Alois Kozubı́kEva SlabákováJán RemšíkZoran ČuligJan BouchalJiřina HofmanováAleš HamplRadek Fedr
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (1 paper)Angewandte Chemie International Edition (2 papers)
- Partner nations
- CzechiaUnited StatesSlovakia
In The Last Decade
Karel Souček
138 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 131
- Cancer Research 608
- Oncology 843
- Molecular Biology 1.7k
- Cell Biology 269
- Immunology 325
Countries citing papers authored by Karel Souček
This map shows the geographic impact of Karel Souček's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karel Souček with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karel Souček more than expected).
Fields of papers citing papers by Karel Souček
This network shows the impact of papers produced by Karel Souček. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karel Souček. The network helps show where Karel Souček may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karel Souček, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 10 | |
| 5 | 2023 | 19 | |
| 6 | 2022 | 6 | |
| 7 | 2020 | 10 | |
| 8 | 2020 | 6 | |
| 9 | 2020 | 43 | |
| 10 | 2017 | 210 | |
| 11 | 2012 | 16 | |
| 12 | Inhibition of topoisomerase IIa: Novel function ofwedelolactone | 2011 | 1 |
| 13 | 2011 | 88 | |
| 14 | 2005 | 29 | |
| 15 | In vitro proliferation of fibrosarcoma cells depends on intactfunctions of lipoxygenases and cytochrome | 2004 | 2 |
| 16 | 2004 | 15 | |
| 17 | 2003 | 7 | |
| 18 | 2001 | 4 | |
| 19 | Spermiologic findings during longterm lithium therapy. | 1981 | 4 |
| 20 | Pharmacogenetic aspects of the lithium treatment of primary affective disorders. | 1978 | 1 |
About Karel Souček
Karel Souček is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 143 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (22 papers), Cancer-related Molecular Pathways (18 papers), Cell death mechanisms and regulation (11 papers), Retinoids in leukemia and cellular processes (10 papers), Prostate Cancer Treatment and Research (9 papers), Estrogen and related hormone effects (7 papers), NF-κB Signaling Pathways (7 papers) and Epigenetics and DNA Methylation (7 papers). The work is most often cited by research in Cancer Research (608 citations), Oncology (843 citations) and Molecular Biology (1.7k citations). Karel Souček has collaborated with scholars based in Czechia, United States and Slovakia. Frequent co-authors include Alois Kozubı́k, Eva Slabáková, Ján Remšík, Zoran Čulig, Jan Bouchal, Jiřina Hofmanová, Aleš Hampl, Radek Fedr, Jan Šmarda and Zuzana Pernicová. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.